MYRF is Essential in Mesothelial Cells to Promote Lung Development and Maturation.

Area of Science:

• Developmental biology
• Cell biology
• Genetics

Background:

• The mesothelium, a protective squamous epithelial layer, is vital for organ function and development.
• The formation and precise role of the mesothelium, particularly in organogenesis, remain incompletely understood.
• Congenital Diaphragmatic Hernia (CDH) is a severe birth defect involving diaphragm and lung malformations, with unclear genetic underpinnings.

Purpose of the Study:

• To investigate the role of the transcription factor gene Myrf in mesothelial development.
• To determine the link between Myrf variants and the pathogenesis of Congenital Diaphragmatic Hernia (CDH).

Main Methods:

• Utilized mouse models with targeted inactivation of the Myrf gene at different developmental stages.
• Analyzed mesothelial specification, differentiation, and function.
• Examined the interplay between MYRF and YAP/TAZ signaling pathways.

Main Results:

• Early inactivation of Myrf led to CDH and impaired mesothelial specification, compromising lung development signaling.
• Later inactivation of Myrf induced mesothelial-to-mesenchymal transition (EMT), causing smooth muscle accumulation around the lung.
• MYRF acts in parallel with YAP/TAZ to regulate mesothelial development.

Conclusions:

• MYRF is identified as a critical regulator of mesothelium development.
• Mutations in MYRF are implicated as a cause of Congenital Diaphragmatic Hernia (CDH).
• Understanding MYRF's function provides insights into CDH etiology and potential therapeutic targets.